Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Disease Progression and CSF3R[original query] |
|---|
| Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies. Journal of cancer research and clinical oncology 2017 Sep . Winkelmann Nils, Schäfer Vivien, Rinke Jenny, Kaiser Alexander, Ernst Philipp, Scholl Sebastian, Hochhaus Andreas, Ernst Thom |
| Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 12 38 (10): 1006-1018. Dao Kim-Hien T, Gotlib Jason, Deininger Michael M N, Oh Stephen T, Cortes Jorge E, Collins Robert H, Winton Elliot F, Parker Dana R, Lee Hyunjung, Reister Anna, Schultz , Savage Samantha, Stevens , Brockett Chase, Subbiah Nan, Press Richard D, Raess Philipp W, Cascio Michael, Dunlap Jennifer, Chen Yiyi, Degnin Catherine, Maxson Julia E, Tognon Cristina E, Macey Tara, Druker Brian J, Tyner Jeffrey |
| CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Annals of hematology 2021 Apr . Qian Yi, Chen Yan, Li Xiaomi |
| Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Current oncology (Toronto, Ont.) 2022 2 29 (2): 805-815. Adam Franziska C, Szybinski Jakub, Halter Jörg P, Cantoni Nathan, Wenzel Friedel, Leonards Katharina, Brkic Sime, Passweg Jakob R, Touw Ivo, Maxson Julia E, Meyer Sara |
| Atypical CML: diagnosis and treatment. Hematology. American Society of Hematology. Education Program 2023 12 2023 (1): 476-482. Massimo Brecc |
- Page last reviewed:Feb 1, 2024
- Content source: